First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer.
Supportive treatment to standard therapy for postmenopausal women with early breast cancer.
Treatment for unknown advanced breast cancer in postmenopausal women.
Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.
Therapeutic Effects:
Inhibits estrogen production by blocking the enzyme aromatase.
Reduces tumor size and stops or slows the progression of the disease.
Avoids recurrence of early-stage breast cancer and improves survival rate.
Interaction with Other Drugs:
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, or herbal products you take or have taken before the treatment.
Certain medications may interact with Oncolet 2.5mg and cause undesirable side effects.
Safety Advices:
Pregnancy: highly unsafe during pregnancy because they may cause harm to the unborn baby. Discuss with your doctor about effective contraceptive methods.
Breastfeeding: unsafe to breastfeed your baby when taking Oncolet 2.5mg tablet. Avoid breastfeeding for at least three weeks after the last dose.
Liver and Lungs: inform your physician if you have liver or lung disease. Dose adjustment may be required.
Alcohol: not recommended to consume alcohol while you are on the treatment with Oncolet 2.5mg tablet as it may cause serious complications.
Driving: caution is required while driving and operating machinery when you take Oncolet 2.5mg tablet as it can cause dizziness, sleepiness, and tiredness.
Side Effects:
Serious: decreased red blood cells, decreased bone mineral density, fluid build-up in lungs.
Common: swelling in the face, eyes, feet, and legs, hot sweats and excessive sweating, hypercholesterolemia (high cholesterol), constipation, heart palpitation, hypertension, diarrhea, loss of appetite, nausea and vomiting, muscle pain, bone pain, and joint stiffness, dizziness, tiredness, and sleepiness, breathing difficulty, arthralgia.
Word of Advice:
Notify your doctor if you have osteoporosis or bone fractures.
Regular monitoring of bone mineral density is necessary while using Oncolet 2.5mg tablet.
Discuss with your doctor if you are planning a pregnancy or have not yet gone through menopause.
Inform your doctor of any sugar intolerance, as the tablet contains lactose ingredients.
If you miss a dose, do not double dose; instead, resume your regular schedule.
FAQs:
Q 1. How does Oncolet 2.5mg tablet work?
Oncolet 2.5mg tablet is an anti-estrogen medication. It reduces estrogen levels in your body by inhibiting the enzyme aromatase, which is responsible for estrogen production. Estrogen stimulates the growth of certain types of breast cancer in your body. Reduced estrogen production may prevent cancer from spreading.
Q 2. Can Oncolet 2.5mg cause mood changes?
Mood changes, such as depression or anxiety, are not common side effects of Oncolet 2.5mg. However, if you experience any changes in mood while taking the medicine, it's important to talk to your doctor.
Q 3. What are the serious side effects of the Oncolet 2.5mg tablet?
The serious side effects do not occur in everyone; very few people experience them. The serious side effects of the Oncolet 2.5mg tablet include stroke, angina, heart attack, blood clotting, cataract, osteoporosis, and fluid build-up in the lungs.
Q 4. Is it better to take Oncolet 2.5mg in the morning or at night?
Your doctor should determine the timing for taking Oncolet 2.5mg based on your specific needs and medical condition. Always follow the doctor's instructions.
Q 5. How often should I have my bone density checked while taking Oncolet 2.5mg?
Oncolet 2.5mg can increase the risk of bone fractures in some people, so it's important to have regular bone density checks while taking the medication. Your doctor will recommend how often you should have these checks.
Q 6. How long is Oncolet 2.5mg taken?
The duration of treatment with Oncolet 2.5mg depends on the specific medical condition and individual response. Follow your doctor's instructions and only stop taking the medication if advised.
Fact Box:
Molecule name: Letrozole
Therapeutic class: Aromatase Inhibitor
Pharmacological class: Anti-Neoplastic drug
Indications: Treatment for early breast cancer in postmenopausal women